SRN-901, a Novel Longevity Drug, Extends Lifespan and Healthspan by Targeting Multiple Aging Pathways
Drug Design, Development and Therapy · 2026-04 · Volume 20 · 1-19
DOI: 10.2147/dddt.s594895 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-04. Verfasst von Brett Weiss und 7 weiteren Autor:innen. Beteiligte Einrichtung: Seragon Biosciences, Irvine, CA, USA. Hauptthemen laut MEDLINE: Longevity, Aging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Seragon Biosciences, Irvine, CA, USA.
- School of Biomedical Engineering, Tsinghua University, Beijing, People's Republic of China.
- Sinopharm-Seragon Biosciences, Beijing, People's Republic of China.
- School of Medicine, Tsinghua University, Beijing, People's Republic of China.
ORCID-Profile: Brett Weiss
Zitieren
APA
Weiss, B., Miranda, D. R., Arrazati, D., Cao, R., Chen, J., Liu, Y., Brown, D., & Marshall, G. (2026). SRN-901, a Novel Longevity Drug, Extends Lifespan and Healthspan by Targeting Multiple Aging Pathways. Drug Design, Development and Therapy, Volume 20, 1-19. https://doi.org/10.2147/dddt.s594895
Vancouver
Weiss B, Miranda DR, Arrazati D, Cao R, Chen J, Liu Y, et al. SRN-901, a Novel Longevity Drug, Extends Lifespan and Healthspan by Targeting Multiple Aging Pathways. Drug Design, Development and Therapy. 2026;Volume 20:1-19. doi:10.2147/dddt.s594895
BibTeX
@article{Weiss2026,
author = {Weiss, Brett and Miranda, Daniel R and Arrazati, Dylan and Cao, Rui and Chen, Jiaqi and Liu, Yongzheng and Brown, David and Marshall, George},
title = {SRN-901, a Novel Longevity Drug, Extends Lifespan and Healthspan by Targeting Multiple Aging Pathways},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--19},
doi = {10.2147/dddt.s594895}
}
EUVIMED